Inhibition of rabbit platelet phosphodiesterase activity and aggregation by calcium channel blockers
- 1 November 1985
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 40 (3) , 401-411
- https://doi.org/10.1016/0049-3848(85)90275-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Dihydropyridine Ca2+ entry blockers selectively inhibit peak I cAMP phosphodiesteraseEuropean Journal of Pharmacology, 1983
- Inhibition of rabbit platelet aggregation by the Ca2+-antagonists verapamil and diltiazem and by trifluoperazineThrombosis Research, 1983
- Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors.Circulation Research, 1983
- Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulinBiochemical and Biophysical Research Communications, 1982
- Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different speciesProstaglandins, 1978
- Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in plateletsNature, 1977
- Stimulation of human platelet adenylate cyclase by prostaglandin D2Thrombosis Research, 1974
- Prostaglandin D2 inhibits the aggregation of human plateletsThrombosis Research, 1974
- Platelet secretion induced by divalent cation ionophoresNature, 1974
- Platelet aggregation IV. Platelet phosphodiesterase and its inhibition by vasodilatorsBiochemical and Biophysical Research Communications, 1971